All charts and data below are with dividends reinvested. (Inflation adjustment is OFF !)
Mon 2012-12-10? to Mon 2024-10-21 |
YTD
Return |
TR
Price |
||||
---|---|---|---|---|---|---|
ABBV × |
+24.78%
2024-10-21 |
8.655 TR
2024-10-21 |
||||
AbbVie Inc NYSE Common Stock | ||||||
Mon 2012-12-10? to Mon 2024-10-21 |
Overall
Return |
Exponential
Trendline |
||||
---|---|---|---|---|---|---|
ABBV × |
+765.47%
+19.95%/yr |
+17.44%/yr
(R2=0.947) |
||||
AbbVie Inc NYSE Common Stock | ||||||
Mon 2012-12-10? to Mon 2024-10-21 |
Start
Value |
End
Value |
||||
---|---|---|---|---|---|---|
ABBV × |
$10,000.00
2012-12-10 |
$86,547.43
2024-10-21 |
||||
AbbVie Inc NYSE Common Stock | ||||||
Year | ABBV |
---|---|
2024 (YTD) | +24.78% |
2023 | −0.23% |
2022 | +24.01% |
2021 | +32.43% |
2020 | +27.72% |
2019 | +1.47% |
2018 | −0.96% |
2017 | +60.07% |
2016 | +9.79% |
2015 | −6.50% |
2014 | +27.92% |
2013 | +60.77% |
2012 | −2.40% |
Mon 2012-12-10? to Mon 2024-10-21 |
Current
Drawdown |
Worst
Drawdown |
||||
---|---|---|---|---|---|---|
ABBV × | −5.67% |
−45.09%
2019-08-15 |
||||
AbbVie Inc NYSE Common Stock | ||||||